Your browser doesn't support javascript.
loading
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.
Blood ; 121(3): 468-75, 2013 Jan 17.
Article in En | MEDLINE | ID: mdl-23086750

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphoproteins / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Ribonucleoprotein, U2 Small Nuclear / Receptor, Notch1 Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2013 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphoproteins / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Ribonucleoprotein, U2 Small Nuclear / Receptor, Notch1 Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2013 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos